This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2022 program include:
- Updated guidelines for the use of biologics in IBD
- Therapeutic drug monitoring in IBD treatment
- Updated guidelines for treatment of C. difficile infection
- Managing GI complications of immunotherapy
- Improved management of IBS and pelvic floor disorders
- Management of refractory GERD
- Expanded genetic testing options to diagnose hereditary GI cancer syndromes
- Management of fatty liver disease in 2022
- Best practices for treatment of HCV
- How to improve your adenoma detection rate (ADR)
- Steps to ensure delivery of high-quality colonoscopic care
- Techniques to effectively control acute GI bleeding
- When FMT is indicated for treatment
- Impact of COVID on GI practice
- New strategies to treat common GI problems
- A comprehensive update of national guidelines
As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:
- IBD
- GI Complications of Immunotherapy
- Microscopic Colitis
- Hepatitis C
- Fatty Liver
- Barrett’s Esophagus
- Eosinophilic Esophagitis
- C. difficile Colitis
- Alcohol-Related Liver Disease
- Autoimmune Hepatitis
- IBS
- Refractory GERD
- Pelvic Floor Disorders
- Acute Pancreatitis
- Chronic Pancreatitis
- Celiac Disease
- GI Bleeding
- High Risk for Colorectal Cancer
- Nutritional Disorders related to GI Conditions
Recent Advances and Innovations
Clinicians can rely on this program for education on:
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- Managing refractory pouchitis
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Antiviral therapies for hepatitis C: how to select which regimen to use? Understanding long-term risks of therapy
- Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
- The stool microbiome: understanding the science behind clinical applications
- Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
- Adenoma detection rates: critical to measure and how to incorporate strategies to increase your rate
This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.
Schedule
Monday, June 13, 2022
| 8:30am to 8:35am | WelcomeDaniel Chung, MD | |
| 8:35am to 9:20am | Which Initial Therapy to Choose to Crohn’s and UC?Joshua Korzenik, MD | |
| 9:20am to 10:00am | Management of Severe UC and Pouch-Related ComplicationsAshwin Ananthakrishnan, MD, MPH | |
| 10:00am to 10:40am | IBD in Special Populations: Pregnancy and the ElderlySonia Friedman, MD | |
| 10:40am to 10:55am | Panel Q&AAshwin Ananthakrishnan, MD, MPH; Sonia Friedman, MD; Joshua Korzenik, MD | |
| 10:55am to 11:10am | Break | |
| 11:10am to 11:45am | WORKSHOP 1: Dermatologic Manifestations of IBDDaniela Kroshinsky, MD | |
| 11:45am to 12:25pm | Therapeutic Drug Monitoring in IBDAdam Cheifetz, MD | |
| 12:25pm to 12:40pm | Panel Q&AAdam Cheifetz, MD; Daniela Kroshinsky, MD | |
| 12:40pm to 1:40pm | Break | |
| 1:40pm to 2:15pm | How to Manage Microscopic ColitisHamed Khalili, MD | |
| 2:15pm to 2:50pm | GI Complications of ImmunotherapyMichael Dougan, MD, PhD | |
| 2:50pm to 3:05pm | Panel Q&AMIchael Dougan, MD, PhD; Hamed Khalili, MD | |
| 3:05pm to 3:20pm | Break | |
| 3:20pm to 3:55pm | What’s New in Hereditary GI CancersDaniel Chung, MD | |
| 3:55pm to 4:30pm | WORKSHOP 2: CRC Screening and How to Improve Your ADRRamona Lim, MD | |
| 4:30pm to 5:05pm | Chemoprevention of CRC: What Should You Recommend?Andrew Chan, MD, MPH | |
| 5:05pm to 5:20pm | Panel Q&AAndrew Chan, MD, MPH; Daniel Chung, MD; Ramona Lim, MD |
Tuesday, June 14, 2022
| 8:30am to 9:05am | Barrett’s Esophagus: Whom and How to Treat?Douglas Pleskow, MD | |
| 9:05am to 9:40am | Esophageal Motility Disorders Made EasyBarbara Nath, MD | |
| 9:40am to 10:15am | Management of Refractory GERDNorman Nishioka, MD | |
| 10:15am to 10:30am | Panel Q&ABarbara Nath, MD; Normal Nishioka, MD; Douglas Pleskow, MD | |
| 10:30am to 10:45am | Break | |
| 10:45am to 11:20am | Comprehensive Approach to Eosinophilic EsophagitisWalter Chan, MD | |
| 11:20am to 12:10pm | Celiac Disease and Gluten Sensitivity: 2022 Practitioner UpdatesCiaran Kelly, MD | |
| 12:10pm to 12:25pm | Panel Q&AWalter Chan, MD; Ciaran Kelly, MD | |
| 12:25pm to 1:30pm | Break | |
| 1:30pm to 2:10pm | Optimizing the Management of GastroparesisBraden Kuo, MD | |
| 2:10pm to 2:50pm | Making the Diagnosis of IBSKyle Staller, MD | |
| 2:50pm to 3:30pm | Modern Strategies to Treat IBSAnthony Lembo, MD | |
| 3:30pm to 3:45pm | Panel Q&ABraden Kuo, MD; Anthony Lembo, MD; Kyle Staller, MD; | |
| 3:45pm to 4:00pm | Break | |
| 4:00pm to 4:30pm | How to Evaluate Small Intestinal Bacterial OvergrowthJudy Nee, MD | |
| 4:30pm to 5:00pm | WORKSHOP 3: Systematic Approaches to Pelvic Floor DisordersMeghan Markowski, PT, DPT | |
| 5:00pm to 5:15pm | Panel Q&AMeghan Markowski, PT, DPT; Judy Nee, MD |
Wednesday, June 15, 2022
| 8:30am to 9:05am | Treating Hepatitis C to EradicationRaymond Chung, MD | |
| 9:05am to 9:45am | Cholestatic Liver Diseases: What’s New in PBC and PSCDaniel Pratt, MD | |
| 9:45am to 10:15am | Update on Autoimmune HepatitisAlan Bonder, MD | |
| 10:15am to 10:30am | Panel Q&AAlan Bonder, MD; Raymond Chung, MD; Daniel Pratt, MD | |
| 10:30am to 10:45am | Break | |
| 10:45am to 11:25am | Alcoholic Liver DiseaseGyongyi Szabo, MD, PhD | |
| 11:25am to 12:00pm | The Epidemic of NAFLDKathleen Corey, MD | |
| 12:00pm to 12:15pm | Panel Q&AKathleen Corey, MD; Gyongyi Szabo, MD | |
| 12:15pm to 1:15pm | Break | |
| 1:15pm to 1:50pm | WORKSHOP 4: How to Workup a Liver NoduleKarin Andersson, MD | |
| 1:50pm to 2:25pm | WORKSHOP 5: How to Approach Drug Induced Liver Injury (DILI)Michael Curry, MD | |
| 2:25pm to 3:05pm | End-Stage Liver Disease and Management of Portal HypertensionAnna Rutherford, MD | |
| 3:05pm to 3:20pm | Panel Q&AKarin Andersson, MD; Michael Curry, MD; Anna Rutherford, MD | |
| 3:20pm to 3:30pm | Break | |
| 3:30pm to 4:05pm | Best Management Strategies in Acute PancreatitisDavid X Jin, MD, MPH | |
| 4:05pm to 4:40pm | Updates in Chronic PancreatitisSunil Sheth, MD | |
| 4:40pm to 5:15pm | Controversies in the Management of Cystic Lesions of the PancreasCarlos Fernandez, MD | |
| 5:15pm to 5:30pm | Panel Q&ACarlos Fernandez, MD; David X Jin, MD, MPH; Sunil Sheth, MD |
Thursday, June 16, 2022
| 8:30am to 9:15am | WORKSHOP 6: Tips for Removing the Difficult PolypTyler Berzin, MD | |
| 9:15am to 9:45am | Quality Measures for Colonoscopy: What’s New and Why It MattersMandeep Sawhney, MD | |
| 9:45am to 10:00am | Panel Q&ATyler Berzin, MD; Mandeep Sawhney, MD | |
| 10:00am to 10:15am | Break | |
| 10:15am to 10:45am | New Insights into the Gut Microbiome and DiseaseRamnik Xavier, MD | |
| 10:45am to 11:25am | COVID in the GI TractWalter Chan, MD | |
| 11:25am to 12:05pm | What’s New in C. difficile ColitisJessica Allegretti, MD, MPH | |
| 12:05pm to 12:20pm | Panel Q&AWalter Chan, MD; Ramnik Xavier, MD | |
| 12:20pm to 1:20pm | Break | |
| 1:20pm to 2:00pm | Endoscopy and the Anticoagulated PatientKunal Jajoo, MD | |
| 2:00pm to 2:40pm | Acute GI Bleeding and Other GI EmergenciesLinda Lee, MD | |
| 2:40pm to 2:55pm | Panel Q&AJessica Allegretti, MD, MPH; Kunal Jajoo, MD; Linda Lee, MD | |
| 2:55pm to 3:10pm | Break | |
| 3:10pm to 3:50pm | WORKSHOP 7: Challenging Cases in GIDouglas Horst, MD | |
| 3:50pm to 4:30pm | GI Management of Obesity and Metabolic DisordersLee Kaplan, MD, PhD | |
| 4:30pm to 5:05pm | Improving Nutritional Management in GI DiseaseAndrew Ukleja, MD | |
| 5:05pm to 5:20pm | Panel Q&ADouglas Horst, MD; Lee Kaplan, MD, PhD; Andrew Ukleja, MD |
Release Date : June 13 – 16, 2022
